Table 1. Included guidelines.
| Guideline | Title | Source | Quality a |
|---|---|---|---|
| NICE (2008) | Prostate cancer: diagnosis and treatment | National Institute for Health and Clinical Excellence | High |
| EAU (2007) | Guidelines on prostate cancer | European Association of Urology | Low |
| CBO (2007) | Guideline on prostate cancer: diagnosis and treatment [Dutch] | Dutch Institute for Healthcare Improvement (CBO) | High |
| NCCN (2007) | Prostate cancer: Clinical Practice Guidelines in Oncology | The National Comprehensive Cancer Network | Low |
| ACB (2007) | Clinical Guidelines: Prostate cancer | Alberta Cancer Board | Low |
| FCCG (2007) | Prostate cancer: Current Care Guidelines [Finnish] | Finnish Medical Society Duodecim | High |
| SBHW (2007) | National guideline for prostate cancer management [Swedish] | Swedish National Board of Health and Welfare | Moderate |
| ESMO (2006) | Prostate cancer: clinical recommendations for diagnosis, treatment and follow-up | European Society for Medical Oncology | Low |
| SOR (2006) | Standards, Options and Recommendations for the management of non-metastatic prostate cancer [French] | French Federation of Comprehensive Cancer Centres and French Urological Association | Moderate |
| CCNS (2006) | Guidelines for the management of prostate cancer | Cancer Care Nova Scotia | Moderate |
| AFU (2005) | Follow-up of prostate cancer [French] | French Urological Association | Low |
| ACR (2005) | Practice guideline for transperineal permanent brachytherapy of prostate cancer | American College of Radiology | Moderate |
| OMHLTC (2002) | PSA Clinical Guidelines | Ontario Ministry of Health and Long-Term Care | Moderate |
| NICE (2002) | Improving Outcomes in Urological Cancers | National Institute for Health and Clinical Excellence | High |
| BCCA (2001) | Cancer Management Guidelines: Prostate | British Colombia Cancer Agency | Low |
| ESTRO (2000) | Recommendations on permanent seed implantation for localised prostate cancer | European Society for Therapeutic Radiology and Oncology | Low |
| AUA (2000) | Prostate-specific antigen (PSA) best practice policy | American Urological Association | Moderate |
| COIN (1999) | Guidelines on the management of prostate cancer | Royal College of Radiology, British Association of Urological Surgeons | Moderate |
Abbreviations: ACB=Alberta Cancer Board; ACR=American College of Radiology; AFU=French Urological Association; AUA=American Urological Association; BCCA=British Colombia Cancer Agency; CBO=Dutch Institute for Healthcare Improvement; CCNS=Cancer Care Nova Scotia; COIN=Royal College of Radiology, British Association of Urological Surgeons; EAU=European Association of Urology; ESMO=European Society for Medical Oncology; ESTRO=European Society for Therapeutic Radiology and Oncology; FCCG=Finnish Current Care Guidelines; NICE=National Institute for Health and Clinical Excellence; NCCN=National Comprehensive Cancer Network; OHMLTC=Ontario Ministry of Health and Long-Term Care; SBHW=Swedish National Board of Health and Welfare; SOR=Standards, Options and Recommendations.
Quality was assessed using the Appraisal of Guidelines Research and Evaluation instrument (www.agreecollaboration.org).